Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taher Al-Tweigeri

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Biomedicines|February 25, 2022
Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast CancerAmal Qattan, Taher Al-Tweigeri, Kausar Suleman
Breast Care (Basel, Switzerland)|July 12, 2021
Ribociclib-Induced Pneumonitis: A Case ReportGhada Algwaiz, Ahmed Ali Badran, Mahmoud A Elshenawy, et al.
International Journal of Molecular Sciences|January 10, 2026
Subtype-Specific m<sup>6</sup>A circRNA Methylation Patterns Identify Epigenetic Biomarker Candidates of Potential Diagnostic and Prognostic Significance in Breast CancerAmal Qattan, Wafa Alkhayal, Kausar Suleman, et al.
Immunotherapy|January 5, 2022
Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancerHazem Ghebeh, Mahmoud A Elshenawy, Adher D AlSayed, et al.
Cancers|September 14, 2024
Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic Triple-Negative Breast Cancer (mTNBC)Amal Qattan, Taher Al-Tweigeri, Kausar Suleman, et al.
International Journal of Molecular Sciences|September 13, 2025
Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44<sup>hi</sup>/CD24<sup>lo</sup>-ALDH1<sup>hi</sup> as an Independent Prognostic Factor After Neoadjuvant ChemotherapyHazem Ghebeh, Jumanah Y Mirza, Taher Al-Tweigeri, et al.
BMC Cancer|February 26, 2008
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapyHazem Ghebeh, Eman Barhoush, Asma Tulbah, et al.
Genes|April 30, 2021
Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-AnalysisAmal Qattan, Taher Al-Tweigeri, Wafa Alkhayal, et al.
The American Journal of Case Reports|November 7, 2019
Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy CombinationAdher D Al Sayed, Mahmoud A Elshenawy, Asma Tulbah, et al.
Oncology Letters|June 29, 2012
The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi womenAbeer Al-Qasem, Mohamed Toulimat, Asma Tulbah, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Biomedicines|February 25, 2022
Translational Implications of Dysregulated Pathways and microRNA Regulation in Quadruple-Negative Breast CancerAmal Qattan, Taher Al-Tweigeri, Kausar Suleman
Breast Care (Basel, Switzerland)|July 12, 2021
Ribociclib-Induced Pneumonitis: A Case ReportGhada Algwaiz, Ahmed Ali Badran, Mahmoud A Elshenawy, et al.
International Journal of Molecular Sciences|January 10, 2026
Subtype-Specific m<sup>6</sup>A circRNA Methylation Patterns Identify Epigenetic Biomarker Candidates of Potential Diagnostic and Prognostic Significance in Breast CancerAmal Qattan, Wafa Alkhayal, Kausar Suleman, et al.
Immunotherapy|January 5, 2022
Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancerHazem Ghebeh, Mahmoud A Elshenawy, Adher D AlSayed, et al.
Cancers|September 14, 2024
Advanced Insights into Competitive Endogenous RNAs (ceRNAs) Regulated Pathogenic Mechanisms in Metastatic Triple-Negative Breast Cancer (mTNBC)Amal Qattan, Taher Al-Tweigeri, Kausar Suleman, et al.
International Journal of Molecular Sciences|September 13, 2025
Profiling of Breast Cancer Stem Cell Types/States Shows the Role of CD44<sup>hi</sup>/CD24<sup>lo</sup>-ALDH1<sup>hi</sup> as an Independent Prognostic Factor After Neoadjuvant ChemotherapyHazem Ghebeh, Jumanah Y Mirza, Taher Al-Tweigeri, et al.
BMC Cancer|February 26, 2008
FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapyHazem Ghebeh, Eman Barhoush, Asma Tulbah, et al.
Genes|April 30, 2021
Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-AnalysisAmal Qattan, Taher Al-Tweigeri, Wafa Alkhayal, et al.
The American Journal of Case Reports|November 7, 2019
Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy CombinationAdher D Al Sayed, Mahmoud A Elshenawy, Asma Tulbah, et al.
Oncology Letters|June 29, 2012
The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi womenAbeer Al-Qasem, Mohamed Toulimat, Asma Tulbah, et al.
Pageof 5